Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies

Autor: Patel, Manish R., Donnellan, William, Byrne, Michael, Asch, Adam S., Zeidan, Amer M., Baer, Maria R., Fathi, Amir T., Kuykendall, Andrew T., Zheng, Fred, Walker, Chris, Cheng, Lulu, Marando, Cindy, Savona, Michael R.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23(9):674-686
Databáze: ScienceDirect
Externí odkaz: